CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: Drummond et al. arrived at similar conclusions, showing a lack of overexpression of TERT and lowered levels of TERC expression in CD34 + cells of CML-CP patients as compared with healthy subjects (Drummond et al. 2005).